Canadian guideline for safe and effective use of opioids for chronic noncancer pain - Clinical summary for family physicians. Part 2: Special populations;Lignes directrices canadiennes sur l'utilisation sécuritaire et efficace des opioïdes pour la douleur chronique non cancéreuse - Résumé clinique pour les médecins de famille. Partie 2: Populations particulières

Canadian Family Physician

Volumn 57, Issue 11, 2011, Pages 1269-1276

  Kahan, Meldon ^a,b   Wilson, Lynn ^a,b   Mailis Gagnon, Angela ^a,c,d   Srivastava, Anita ^a,e  

^a UNIVERSITY OF TORONTO   (Canada)

^b ST JOSEPH S HEALTH CENTRE   (Canada)

^c TORONTO WESTERN HOSPITAL   (Canada)

^d ACTION Ontario Centre for the Study of Pain   (Canada)

^e CENTRE FOR ADDICTION AND MENTAL HEALTH   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BENZODIAZEPINE; BUPRENORPHINE; BUPRENORPHINE PLUS NALOXONE; CODEINE; HYDROMORPHONE; METHADONE; MORPHINE; OPIATE; TRAMADOL;

ABSTINENCE; ANALGESIA; ANXIETY; ANXIETY DISORDER; CHRONIC PAIN; CLINICAL FEATURE; DELIRIUM; DRUG DETOXIFICATION; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG MISUSE; DRUG OVERDOSE; DRUG SAFETY; DRUG SCREENING; DRUG TOLERANCE; DYSPHORIA; EUPHORIA; GENERAL PRACTITIONER; HIGH RISK PATIENT; HIP FRACTURE; HUMAN; HYPERALGESIA; INSOMNIA; MENTAL DISEASE; MOOD DISORDER; MYALGIA; NAUSEA; NEUROPATHIC PAIN; NOCICEPTION; OPIATE ADDICTION; PATIENT COUNSELING; PATIENT EDUCATION; PRACTICE GUIDELINE; PREGNANT WOMAN; PREVALENCE; RESPIRATION DEPRESSION; REVIEW; SEDATION; SUBSTANCE ABUSE; WITHDRAWAL SYNDROME;

ADOLESCENT; AGE FACTORS; AGED; AGED, 80 AND OVER; ANALGESICS, OPIOID; ANXIETY DISORDERS; CANADA; CHRONIC PAIN; FEMALE; HUMANS; HYPNOTICS AND SEDATIVES; MOOD DISORDERS; NEURALGIA; NOCICEPTIVE PAIN; OPIOID-RELATED DISORDERS; PREGNANCY; PREGNANCY COMPLICATIONS; RISK ASSESSMENT;

EID: 81855218050     PISSN: 0008350X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (65)

1. Dhalla IA, Mamdani MM, Sivilotti ML, Kopp A, Qureshi O, Juurlink DN. Prescribing of opioid analgesics and related mortality before and after the introduction of long-acting oxycodone. CMAJ 2009;181(12):891-6. Cyberpub. du 7 décembre 2009.
2. Sproule B, Brands B, Li S, Catz-Biro L. Changing patterns in opioid addiction. Characterizing users of oxycodone and other opioids. Can Fam Physician 2009;55(1):68-9. e1-5. Accessible à: www.cfp.ca/content/55/1/ 68. Accédéle 16 septembre 2011.
3. National Opioid Use Guideline Group. Canadian guideline for safe and effective use of opioids for chronic non-cancer pain. Hamilton, ON: McMaster University; 2010. Accessible à: http://nationalpaincentre.mcmaster.ca/ opioid/cgop-a00-executive-summary.html. Accédé le 20 septembre 2011.
4. Kahan M, Mailis-Gagnon A, Wilson L, Srivastava A. Canadian guideline for safe and effective use of opioids for chronic noncancer pain. Clinical summary for family physicians. Part 1: general populations. Can Fam Physician 2011;57:000-0 (ang), e000-0 (fr).
5. Fishbain DA, Cole B, Lewis J, Rosomoff HL, Rosomoff RS. What percentage of chronic nonmalignant pain patients exposed to chronic opioid analgesic therapy develop abuse/addiction and/or aberrant drug-related behaviors? A structured evidence-based review. Pain Med 2008;9(4):444-59. (Pubitemid 351722518)
6. Fischer B, Rehm J, Patra J. Changes in illicit opioid use across Canada. CMAJ 2006;175(11):1385-7. (Pubitemid 44876556)
7. Kuehn BM. Opioid prescriptions soar: increase in legitimate use as well as abuse. JAMA 2007;297(3):249-51. (Pubitemid 46143290)
8. Dasgupta N, Kramer ED, Zalman MA, Carino S Jr, Smith MY, Haddox JD et collab. Association between non-medical and prescriptive usage of opioids. Drug Alcohol Depend 2006;82(2):135-42. Cyberpub. du 16 octobre 2005.
9. College of Physicians and Surgeons of Ontario. Avoiding abuse, achieving a balance: tackling the opioid public health crisis. Opioid Project. Toronto, ON: College of Physicians and Surgeons of Ontario; 2010. Accessible à: www. cpso.on.ca/policies/positions/default.aspx?id=4324. Accédé le 16 septembre 2011.
10. Centre for Addiction and Mental Health. Low-risk drinking guidelines. Toronto, ON: Centre for Addiction and Mental Health; 2004.
11. Webster LR, Webster RM. Predicting aberrant behaviors in opioidtreated patients: preliminary validation of the Opioid Risk Tool. Pain Med 2005;6(6):432-42. (Pubitemid 43110296)
12. Turk DC, Swanson KS, Gatchel RJ. Predicting opioid misuse by chronic pain patients: a systematic review and literature synthesis. Clin J Pain 2008;24(6):497-508.
13. Brands B, Brands J. Methadone maintenance: a physicians guide to treatment. Toronto, ON: Addiction Research Foundation; 1998.
14. Manchikanti L, Manchukonda R, Damron KS, Brandon D, McManus CD, Cash K. Does adherence monitoring reduce controlled substance abuse in chronic pain patients? Pain Physician 2006;9(1):57-60. (Pubitemid 43263665)
15. Manchikanti L, Manchukonda R, Pampati V, Damron KS, Brandon DE, Cash KA et collab. Does random urine drug testing reduce illicit drug use in chronic pain patients receiving opioids? Pain Physician 2006;9(2):123-9.
16. Passik SD, Kirsh KL. Assessing aberrant drug-taking behaviors in the patient with chronic pain. Curr Pain Headache Rep 2004;8(4):289-94. (Pubitemid 39117319)
17. Butler SF, Benoit C, Budman SH, Fernandez KC, McCormick C, Venuti SW et collab. Development and validation of an Opioid Attractiveness Scale: a novel measure of the attractiveness of opioid products to potential abusers. Harm Reduct J 2006;3:5.
18. Cicero TJ, Dart RC, Inciardi JA, Woody GE, Schnoll S, Munoz A. The development of a comprehensive riskmanagement program for prescription opioid analgesics: researched abuse, diversion and addiction-related surveillance (RADARS). Pain Med 2007;8(2):157-70.
19. Zacny JP, Gutierrez S. Characterizing the subjective, psychomotor, and physiological effects of oral oxycodone in non-drug-abusing volunteers. Psychopharmacology (Berl) 2003;170(3):242-54. Cyberpub. du 29 aoÛt 2003.
20. Zacny JP, Lichtor SA. Within-subject comparison of the psychopharmacological profiles of oral oxycodone and oral morphine in non-drug-abusing volunteers. Psychopharmacology (Berl) 2008;196(1):105-16. Cyberpub. du 27 septembre 2007.
21. Mailis-Gagnon A, Kahan M. Pocket atlas for appropriate opioid prescribing for CNCP. Toronto, ON: Elafi; 2010.
22. Jamison RN, Ross EL, Michna E, Chen LQ, Holcomb C, Wasan AD. Substance misuse treatment for high-risk chronic pain patients on opioid therapy: a randomized trial. Pain 2010;150(3):390-400. Cyberpub. du 23 mars 2010.
23. Currie SR, Hodgins DC, Crabtree A, Jacobi J, Armstrong S. Outcome from integrated pain management treatment for recovering substance abusers. J Pain 2003;4(2):91-100. (Pubitemid 36337420)
24. Chelminski PR, Ives TJ, Felix KM, Prakken SD, Miller TM, Perhac JS et collab. A primary care, multi-disciplinary disease management program for opioid-treated patients with chronic non-cancer pain and a high burden of psychiatric comorbidity. BMC Health Serv Res 2005;5(1):3.
25. Wiedemer NL, Harden PS, Arndt IO, Gallagher RM. The opioid renewal clinic: a primary care, managed approach to opioid therapy in chronic pain patients at risk for substance abuse. Pain Med 2007;8(7):573-84. (Pubitemid 47490213)
26. Ilgen MA, Trafton JA, Humphreys K. Response to methadone maintenance treatment of opiate dependent patients with and without significant pain. Drug Alcohol Depend 2006;82(3):187-93. Cyberpub. du 10 octobre 2005.
27. Auriacombe M, Franques P, Tignol J. Deaths attributable to methadone vs buprenorphine in France. JAMA 2001;285(1):45. (Pubitemid 32042714)
28. Fiellin DA, Pantalon MV, Pakes JP, O'Connor PG, Chawarski M, Schottenfeld RS. Treatment of heroin dependence with buprenorphine in primary care. Am J Drug Alcohol Abuse 2002;28(2):231-41. (Pubitemid 34457057)
29. Caplehorn JR. A comparison of buprenorphine treatment in clinic and primary care settings: a randomised trial. Med J Aust 2003;179(10):557-8. (Pubitemid 37461087)
30. Barry DT, Moore BA, Pantalon MV, Chawarski MC, Sullivan LE, O'Connor PG et collab. Patient satisfaction with primary care officebased buprenorphine/ naloxone treatment. J Gen Intern Med 2007;22(2):242-5. (Pubitemid 47308818)
31. Kahan M, Srivastava A, Ordean A, Cirone S. Buprenorphine. New treatment of opioid addiction in primary care. Can Fam Physician 2011;57:281-9.
32. Sullivan MD, Edlund MJ, Steffick D, Unutzer J. Regular use of prescribed opioids: association with common psychiatric disorders. Pain 2005;119(1-3): 95-103. (Pubitemid 41752969)
33. Sullivan MD, Edlund MJ, Zhang L, Unutzer J, Wells KB. Association between mental health disorders, problem drug use, and regular prescription opioid use. Arch Intern Med 2006;166(19):2087-93. (Pubitemid 44631396)
34. Breckenridge J, Clark JD. Patient characteristics associated with opioid versus nonsteroidal anti-inflammatory drug management of chronic low back pain. J Pain 2003;4(6):344-50. (Pubitemid 37013026)
35. Wasan AD, Davar G, Jamison R. The association between negative affect and opioid analgesia in patients with discogenic low back pain. Pain 2005;117(3):450-61. (Pubitemid 41383540)
36. Levenson JL, McClish DK, Dahman BA, Bovbjerg VE, de A Citero V, Penberthy LT et collab. Depression and anxiety in adults with sickle cell disease: the PiSCES project. Psychosom Med 2008;70(2):192-6. Cyberpub. du 24 décembre 2007.
37. Riley JL 3rd, Hastie BA. Individual differences in opioid efficacy for chronic noncancer pain. Clin J Pain 2008;24(6):509-20.
38. Becker WC, Sullivan LE, Tetrault JM, Desai RA, Fiellin DA. Non-medical use, abuse and dependence on prescription opioids among U.S. adults: psychiatric, medical and substance use correlates. Drug Alcohol Depend 2008;94(1-3): 38-47. Cyberpub. du 11 décembre 2007.
39. Manchikanti L, Giordano J, Boswell MV, Fellows B, Manchukonda R, Pampati V. Psychological factors as predictors of opioid abuse and illicit drug use in chronic pain patients. J Opioid Manag 2007;3(2):89-100. (Pubitemid 46760149)
40. Wilsey BL, Fishman SM, Tsodikov A, Ogden C, Symreng I, Ernst A. Psychological comorbidities predicting prescription opioid abuse among patients in chronic pain presenting to the emergency department. Pain Med 2008;9(8):1107-17. Cyberpub. du 5 février 2008 .
41. Voaklander DC, Rowe BH, Dryden DM, Pahal J, Saar P, Kelly KD. Medical illness, medication use and suicide in seniors: a population-based case-control study. J Epidemiol Community Health 2008;62(2):138-46. (Pubitemid 351196854)
42. Cone EJ, Fant RV, Rohay JM, Caplan YH, Ballina M, Reder RF et collab. Oxycodone involvement in drug abuse deaths: a DAWN-based classification scheme applied to an oxycodone postmortem database containing over 1000 cases. J Anal Toxicol 2003;27(2):57-67. (Pubitemid 36292977)
43. Burns JM, Martyres RF, Clode D, Boldero JM. Overdose in young people using heroin: associations with mental health, prescription drug use and personal circumstances. Med J Aust 2004;181(7 Suppl):S25-8. (Pubitemid 39341673)
44. Townsend CO, Kerkvliet JL, Bruce BK, Rome JD, Hooten WM, Luedtke CA et collab. A longitudinal study of the efficacy of a comprehensive pain rehabilitation program with opioid withdrawal: comparison of treatment outcomes based on opioid use status at admission. Pain 2008;140(1):177-89. Cyberpub. du 19 septembre 2008.
45. Moulin DE, Clark AJ, Speechley M, MorleyForster PK. Chronic pain in Canada - prevalence, treatment, impact and the role of opioid analgesia. Pain Res Manag 2002;7(4):179-84. (Pubitemid 36215849)
46. Morley-Forster PK, Clark AJ, Speechley M, Moulin DE. Attitudes toward opioid use for chronic pain: a Canadian physician survey. Pain Res Manag 2003;8(4):189-94. (Pubitemid 43020581)
47. Solomon DH, Avorn J, Wang PS, Vaillant G, Cabral D, Mogun H et collab. Prescription opioid use among older adults with arthritis or low back pain. Arthritis Rheum 2006;55(1):35-41. (Pubitemid 43235125)
48. Ytterberg SR, Mahowald ML, Woods SR. Codeine and oxycodone use in patients with chronic rheumatic disease pain. Arthritis Rheum 1998;41(9):1603-12. (Pubitemid 28459918)
49. Mahowald ML, Singh JA, Majeski P. Opioid use by patients in an orthopedics spine clinic. Arthritis Rheum 2005;52(1):312-21. (Pubitemid 40129264)
50. Shorr RI, Griffin MR, Daugherty JR, Ray WA. Opioid analgesics and the risk of hip fracture in the elderly: codeine and propoxyphene. J Gerontol 1992;47(4):M111-5.
51. Vestergaard P, Rejnmark L, Mosekilde L. Fracture risk associated with the use of morphine and opiates. J Intern Med 2006;260(1):76-87. (Pubitemid 43894073)
52. Hartikainen S, Mäntyselkä P, LouhivuoriLaako K, Enlund H, Sulkava R. Concomitant use of analgesics and psychotropics in home-dwelling elderly people - Kuopio 75+ study. Br J Clin Pharmacol 2005;60(3):306-10. (Pubitemid 41224139)
53. Solomon DH, Rassen JA, Glynn RJ, Lee J, Levin R, Schneeweiss S. Comparative safety of analgesics in older adults with arthritis. Arch Intern Med 2010;170(22):1968-76. Erratum dans: Arch Intern Med 2011;171(5):403.
54. Clegg A, Young JB. Which medications to avoid in people at risk of delirium: a systematic review. Age Ageing 2011;40(1):23-9. Cyberpub. du 9 novembre 2010.
55. Freye E, Levy JV. [Use of opioids in the elderly - pharmacokinetic and pharmacodynamic considerations.] Article en allemand. Anasthesiol Intensivmed Notfallmed Schmerzther 2004;39(9):527-37. (Pubitemid 39263666)
56. WilderSmith OH. Opioid use in the elderly. Eur J Pain 2005;9(2):137-40.
57. Kandall SR, Doberczak TM, Jantunen M, Stein J. The methadone-maintained pregnancy. Clin Perinatol 1999;26(1):173-83. (Pubitemid 29177807)
58. Adlaf EM, Paglia-Boak A, Brands B. Use of OxyContin by adolescent students. CMAJ 2006;174(9):1303.
59. McCabe SE, West BT, Morales M, Cranford JA, Boyd CJ. Does early onset of non-medical use of prescription drugs predict subsequent prescription drug abuse and dependence? Results from a national study. Addiction 2007;102(12):1920-30. Cyberpub. du 4 octobre 2007.
60. Broussard CS, Rasmussen SA, Reefhuis J, Friedman JM, Jann MW, RiehleColarusso T et collab. Maternal treatment with opioid analgesics and risks for birth defects. Am J Obs Gyn 2011;204(4):314.e1-11. Cyberpub. du 21 février 2011.
61. Hadi I, da Silva O, Natale R, Boyd D, Morley-Forster PK. Opioids in the parturient with chronic nonmalignant pain: a retrospective review. J Opioid Manag 2006;2(1):31-4.
62. Madadi P, Shirazi F, Walter FG, Koren G. Establishing causality of CNS depression in breastfed infants following maternal codeine use. Paediatr Drugs 2008;10(6):399-404.
63. Kaltenbach K, Berghella V, Finnegan L. Opioid dependence during pregnancy. Effects and management. Obstet Gynecol Clin North Am 1998;25(1):139-51. (Pubitemid 28141705)
64. Johnson RE, Jones HE, Fischer G. Use of buprenorphine in pregnancy: patient management and effects on the neonate. Drug Alcohol Depend 2003;70(2 Suppl):S87-101.
65. Lacroix I, Berrebi A, Chaumerliac C, Lapeyre-Mestre M, Montastruc JL, Damase-Michel C. Buprenorphine in pregnant opioid-dependent women: first results of a prospective study. Addiction 2004;99(2):109-14.